Cargando…
Expression of Master Regulators of T-cell, Helper T-cell and Follicular Helper T-cell Differentiation in Angioimmunoblastic T-cell Lymphoma
OBJECTIVE: It has been postulated that the normal counterpart of angioimmunoblastic T-cell lymphoma (AITL) is the follicular helper T-cell (TFH). Recent immunological studies have identified several transcription factors responsible for T-cell differentiation. The master regulators associated with T...
Autores principales: | Matsumoto, Yosuke, Nagoshi, Hisao, Yoshida, Mihoko, Kato, Seiichi, Kuroda, Junya, Shimura, Kazuho, Kaneko, Hiroto, Horiike, Shigeo, Nakamura, Shigeo, Taniwaki, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709626/ https://www.ncbi.nlm.nih.gov/pubmed/28943543 http://dx.doi.org/10.2169/internalmedicine.8570-16 |
Ejemplares similares
-
Hairy B-Cell Lymphoproliferative Disorder and its Differential Diagnosis: a Case with Long-Term Follow-Up
por: Matsuda, Kensuke, et al.
Publicado: (2017) -
Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome
por: Shimura, Yuji, et al.
Publicado: (2014) -
Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling
por: Taniwaki, Masafumi, et al.
Publicado: (2018) -
Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy
por: Kaneko, Hiroto, et al.
Publicado: (2022) -
Detection of novel and recurrent conjoined genes in non-Hodgkin B-cell
lymphoma
por: Matsumoto, Yosuke, et al.
Publicado: (2021)